HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of dorzolamide for patients with X-linked retinoschisis.

AbstractPURPOSE:
To determine the value of a topical carbonic anhydrase inhibitor for the treatment of foveal lesions in patients with X-linked retinoschisis (XLRS).
METHODS:
Eight patients with XLRS and foveal cystic-appearing spaces by fundus examination and by optical coherence tomography (OCT) were treated with a topical form of carbonic anhydrase inhibitor. Changes in "foveal thickness" and "foveal zone thickness" were measured by OCT, and changes of best-corrected visual acuity were measured by Early Treatment Diabetic Retinopathy Study (ETDRS) charts.
RESULTS:
Seven of eight patients treated with 2% dorzolamide had a noticeable reduction in foveal thickness as well as cystic-appearing spaces by OCT. This reduction was found in both eyes in four of these patients and in one eye in one patient after 1 month of treatment. After an additional 1 month to 2 months of the same treatment regimen, two additional patients also had a noticeable reduction in foveal thickness as well as cystic-appearing spaces. Of these seven patients who had an improvement shown by OCT with treatment, five also had improvement of their visual acuity by >or=7 letters in at least one eye on ETDRS charts.
CONCLUSION:
The present study shows the efficacy of topical dorzolamide for treating foveal cystic-appearing lesions in patients with XLRS.
AuthorsMarsha A Apushkin, Gerald A Fishman
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 26 Issue 7 Pg. 741-5 (Sep 2006) ISSN: 0275-004X [Print] United States
PMID16963845 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbonic Anhydrase Inhibitors
  • Ophthalmic Solutions
  • Sulfonamides
  • Thiophenes
  • dorzolamide
Topics
  • Administration, Topical
  • Adult
  • Carbonic Anhydrase Inhibitors (therapeutic use)
  • Cysts (diagnosis, drug therapy)
  • Fovea Centralis (drug effects)
  • Humans
  • Middle Aged
  • Ophthalmic Solutions (therapeutic use)
  • Prospective Studies
  • Retinoschisis (diagnosis, drug therapy)
  • Sulfonamides (therapeutic use)
  • Thiophenes (therapeutic use)
  • Tomography, Optical Coherence
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: